Oncology and Hematology News and Journal Articles
The addition of pegylated interferon-ɑ2b to dasatinib yielded promising results in a small trial of newly diagnosed chronic myeloid leukemia patients.
The KEYNOTE-012 trial shows that pembrolizumab has activity and acceptable toxicity as single-agent therapy in advanced triple-negative breast cancer.
Blood transfusions play a key role in managing complications of acute promyelocytic leukemia (APL), involving unique blood product strategies.
Precautions should be taken when handling chemotherapy and other hazardous drugs, as they can cause acute or chronic effects in nurses and healthcare providers.
Cognitive behavioral therapy may reduce long-term memory-related issues linked to chemotherapy treatment in cancer survivors.
While oncologic emergencies are common among cancer patients, they can often be avoided with close monitoring, early intervention, and ongoing patient education.
In this video, Dr. Paz-Ares discusses a phase III study that showed that nivolumab improved survival and response rates in previously treated patients with metastatic non-squamous non-small-cell lung cancer (NSCLC).
In this video, Steven I. Sherman, MD, discusses the final overall survival analysis of the EXAM study, a randomized, placebo-controlled phase III trial of cabozantinib in medullary thyroid carcinoma patients.
In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
In this video, Dr. Tap discusses a randomized phase Ib/II trial that found that adding olaratumab to doxorubicin dramatically improved survival in patients with advanced soft-tissue sarcoma.
The journal ONCOLOGY includes a cartoon at the end of each issue. Here are the collected cartoons to date.